- Home
- IMMX vs CIVB Comparison
IMMX vs CIVB Comparison
Compare IMMX & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMMX | CIVB |
|---|---|---|
| Founded | 2014 | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 716.2M | 591.5M |
| IPO Year | 2021 | 2012 |
Fundamental Metrics
Financial Performance| Metric | IMMX | CIVB |
|---|---|---|
| Price | $8.52 | $28.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | $19.20 | ★ $26.60 |
| AVG Volume (30 Days) | ★ 2.1M | 143.7K |
| Earning Date | 05-08-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | N/A | ★ 31.34 |
| EPS | N/A | ★ 0.72 |
| Revenue | N/A | ★ $19,023,000.00 |
| Revenue This Year | N/A | $14.88 |
| Revenue Next Year | N/A | $5.99 |
| P/E Ratio | ★ N/A | $39.29 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.94 | $18.95 |
| 52 Week High | $12.14 | $29.38 |
Technical Indicators
Market Signals| Indicator | IMMX | CIVB |
|---|---|---|
| Relative Strength Index (RSI) | 39.80 | 60.52 |
| Support Level | $7.99 | $26.21 |
| Resistance Level | $9.37 | $29.31 |
| Average True Range (ATR) | 0.90 | 0.81 |
| MACD | -0.28 | -0.04 |
| Stochastic Oscillator | 1.93 | 86.29 |
Price Performance
Historical ComparisonAbout IMMX Immix Biopharma Inc.
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.